Session 1:
How Patent Prosecution Strategy and Licensing Fundamentals Shape Startup IP Protection | October 1, 2025
Instructor(s)
Kathryn Grey, PhD, Fish & Richardson
Alex Yu,Fish & Richardson
Session 2:
Patent Prosecution, Litigation, and FDA Regulatory Strategy for Medical Device Startups | October 8, 2025
Instructor(s)
Tyler Train, Fish & Richardson
Giordana Mahn, Fish & Richardson
Session 3:
Patent Chain of Title: How Broken Assignment Links Destroy IP Portfolio Value | October 15, 2025
Instructor(s)
Priscilla Dodson, Covington
Session 4:
Patents, Trade Secrets, and the Hatch-Waxman Act in Life Sciences IP Strategy | October 22, 2025
Instructor(s)
Robert Frederickson III, Goodwin
Olivia Uitto, PhD, Goodwin
Session 5:
Ratigan and the Economic Loss Rule: Fraudulent Concealment Liability in Technology Consulting Agreements | October 28, 2025
Instructor(s)
Brent Sokol,Greenberg Traurig
Alex Linhardt,Greenberg Traurig
Session 6:
Pre-Litigation IP Readiness for Life Sciences Startups: Cease-and-Desist Letters, Willful Infringement, and Venue Strategy | November 5, 2025
Instructor(s)
Natasha Daughtrey, Goodwin
Josh Weinger, PhD, Goodwin
Session 7:
Hatch-Waxman and the BPCIA: How Two Statutes Govern the Drug and Biologic Patent Lifecycle | November 12, 2025
Instructor(s)
Madelyn McCormick, Fish & Richardson
Dexter Whitley, PhD, Fish & Richardson
Session 8:
Revlon Duties, Business Judgment, and Entire Fairness: Delaware Fiduciary Law in Life Sciences M&A | November 18, 2025
Instructor(s)
Lisa Haddad, Goodwin
Caroline Bullerjahn, Goodwin